nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—amyotrophic lateral sclerosis	0.569	0.837	CbGaD
Acetylsalicylic acid—PTGS2—amyotrophic lateral sclerosis	0.111	0.164	CbGaD
Acetylsalicylic acid—TP53—forelimb—amyotrophic lateral sclerosis	0.00848	0.0867	CbGeAlD
Acetylsalicylic acid—TP53—arm—amyotrophic lateral sclerosis	0.00728	0.0745	CbGeAlD
Acetylsalicylic acid—TP53—appendage—amyotrophic lateral sclerosis	0.00654	0.0669	CbGeAlD
Acetylsalicylic acid—TP53—manus—amyotrophic lateral sclerosis	0.00649	0.0663	CbGeAlD
Acetylsalicylic acid—NFKBIA—nerve—amyotrophic lateral sclerosis	0.00456	0.0467	CbGeAlD
Acetylsalicylic acid—HSPA5—nerve—amyotrophic lateral sclerosis	0.00447	0.0457	CbGeAlD
Acetylsalicylic acid—TP53—hindbrain—amyotrophic lateral sclerosis	0.00347	0.0355	CbGeAlD
Acetylsalicylic acid—NFKBIA—hindbrain—amyotrophic lateral sclerosis	0.00342	0.035	CbGeAlD
Acetylsalicylic acid—HSPA5—hindbrain—amyotrophic lateral sclerosis	0.00335	0.0342	CbGeAlD
Acetylsalicylic acid—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00314	0.0566	CcSEcCtD
Acetylsalicylic acid—Gout—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0421	CcSEcCtD
Acetylsalicylic acid—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0416	CcSEcCtD
Acetylsalicylic acid—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00222	0.0401	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0393	CcSEcCtD
Acetylsalicylic acid—TP53—embryo—amyotrophic lateral sclerosis	0.00217	0.0222	CbGeAlD
Acetylsalicylic acid—NFKBIA—embryo—amyotrophic lateral sclerosis	0.00214	0.0219	CbGeAlD
Acetylsalicylic acid—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00213	0.0384	CcSEcCtD
Acetylsalicylic acid—HSPA5—embryo—amyotrophic lateral sclerosis	0.00209	0.0214	CbGeAlD
Acetylsalicylic acid—Coma—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0359	CcSEcCtD
Acetylsalicylic acid—TP53—brainstem—amyotrophic lateral sclerosis	0.00199	0.0204	CbGeAlD
Acetylsalicylic acid—NFKBIA—brainstem—amyotrophic lateral sclerosis	0.00196	0.02	CbGeAlD
Acetylsalicylic acid—HSPA5—brainstem—amyotrophic lateral sclerosis	0.00192	0.0196	CbGeAlD
Acetylsalicylic acid—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0328	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—embryo—amyotrophic lateral sclerosis	0.00178	0.0182	CbGeAlD
Acetylsalicylic acid—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0319	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0319	CcSEcCtD
Acetylsalicylic acid—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00166	0.03	CcSEcCtD
Acetylsalicylic acid—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0296	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0286	CcSEcCtD
Acetylsalicylic acid—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00147	0.015	CbGeAlD
Acetylsalicylic acid—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00144	0.026	CcSEcCtD
Acetylsalicylic acid—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0247	CcSEcCtD
Acetylsalicylic acid—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0247	CcSEcCtD
Acetylsalicylic acid—NFKBIA—medulla oblongata—amyotrophic lateral sclerosis	0.00137	0.014	CbGeAlD
Acetylsalicylic acid—HSPA5—medulla oblongata—amyotrophic lateral sclerosis	0.00134	0.0137	CbGeAlD
Acetylsalicylic acid—IKBKB—embryo—amyotrophic lateral sclerosis	0.00132	0.0135	CbGeAlD
Acetylsalicylic acid—PTGS2—appendage—amyotrophic lateral sclerosis	0.00126	0.0129	CbGeAlD
Acetylsalicylic acid—TP53—spinal cord—amyotrophic lateral sclerosis	0.00124	0.0127	CbGeAlD
Acetylsalicylic acid—NFKBIA—spinal cord—amyotrophic lateral sclerosis	0.00122	0.0125	CbGeAlD
Acetylsalicylic acid—HSPA5—spinal cord—amyotrophic lateral sclerosis	0.00119	0.0122	CbGeAlD
Acetylsalicylic acid—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0211	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—medulla oblongata—amyotrophic lateral sclerosis	0.00114	0.0117	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0199	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0198	CcSEcCtD
Acetylsalicylic acid—TP53—nervous system—amyotrophic lateral sclerosis	0.00104	0.0107	CbGeAlD
Acetylsalicylic acid—NFKBIA—nervous system—amyotrophic lateral sclerosis	0.00103	0.0105	CbGeAlD
Acetylsalicylic acid—RPS6KA3—spinal cord—amyotrophic lateral sclerosis	0.00102	0.0104	CbGeAlD
Acetylsalicylic acid—HSPA5—nervous system—amyotrophic lateral sclerosis	0.00101	0.0103	CbGeAlD
Acetylsalicylic acid—TP53—central nervous system—amyotrophic lateral sclerosis	0.001	0.0103	CbGeAlD
Acetylsalicylic acid—NFKBIA—central nervous system—amyotrophic lateral sclerosis	0.000988	0.0101	CbGeAlD
Acetylsalicylic acid—TP53—cerebellum—amyotrophic lateral sclerosis	0.000982	0.01	CbGeAlD
Acetylsalicylic acid—HSPA5—central nervous system—amyotrophic lateral sclerosis	0.000968	0.0099	CbGeAlD
Acetylsalicylic acid—NFKBIA—cerebellum—amyotrophic lateral sclerosis	0.000966	0.00988	CbGeAlD
Acetylsalicylic acid—HSPA5—cerebellum—amyotrophic lateral sclerosis	0.000946	0.00967	CbGeAlD
Acetylsalicylic acid—EDNRA—medulla oblongata—amyotrophic lateral sclerosis	0.000926	0.00947	CbGeAlD
Acetylsalicylic acid—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000882	0.0159	CcSEcCtD
Acetylsalicylic acid—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000877	0.0158	CcSEcCtD
Acetylsalicylic acid—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000872	0.0157	CcSEcCtD
Acetylsalicylic acid—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000857	0.0155	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—nervous system—amyotrophic lateral sclerosis	0.000856	0.00876	CbGeAlD
Acetylsalicylic acid—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000856	0.0154	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000854	0.0154	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000839	0.0151	CcSEcCtD
Acetylsalicylic acid—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000827	0.0149	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—central nervous system—amyotrophic lateral sclerosis	0.000824	0.00843	CbGeAlD
Acetylsalicylic acid—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000824	0.0148	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000812	0.0146	CcSEcCtD
Acetylsalicylic acid—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000812	0.0146	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—cerebellum—amyotrophic lateral sclerosis	0.000806	0.00824	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—amyotrophic lateral sclerosis	0.000805	0.338	CrCbGaD
Acetylsalicylic acid—TP53—brain—amyotrophic lateral sclerosis	0.000797	0.00815	CbGeAlD
Acetylsalicylic acid—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000785	0.0142	CcSEcCtD
Acetylsalicylic acid—NFKBIA—brain—amyotrophic lateral sclerosis	0.000784	0.00802	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000779	0.014	CcSEcCtD
Acetylsalicylic acid—HSPA5—brain—amyotrophic lateral sclerosis	0.000768	0.00786	CbGeAlD
Acetylsalicylic acid—Shock—Riluzole—amyotrophic lateral sclerosis	0.000766	0.0138	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000762	0.0137	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00076	0.0137	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000753	0.0136	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000694	0.0125	CcSEcCtD
Acetylsalicylic acid—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000692	0.0125	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000685	0.0124	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—brain—amyotrophic lateral sclerosis	0.000654	0.00669	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000642	0.0116	CcSEcCtD
Acetylsalicylic acid—IKBKB—nervous system—amyotrophic lateral sclerosis	0.000632	0.00646	CbGeAlD
Acetylsalicylic acid—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000619	0.0111	CcSEcCtD
Acetylsalicylic acid—IKBKB—central nervous system—amyotrophic lateral sclerosis	0.000608	0.00622	CbGeAlD
Acetylsalicylic acid—IKBKB—cerebellum—amyotrophic lateral sclerosis	0.000595	0.00608	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000574	0.0103	CcSEcCtD
Acetylsalicylic acid—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000551	0.00993	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000533	0.0096	CcSEcCtD
Acetylsalicylic acid—EDNRA—brain—amyotrophic lateral sclerosis	0.000532	0.00544	CbGeAlD
Acetylsalicylic acid—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000515	0.00928	CcSEcCtD
Acetylsalicylic acid—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000495	0.00892	CcSEcCtD
Acetylsalicylic acid—Rash—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00885	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00884	CcSEcCtD
Acetylsalicylic acid—IKBKB—brain—amyotrophic lateral sclerosis	0.000483	0.00494	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—amyotrophic lateral sclerosis	0.000469	0.197	CrCbGaD
Acetylsalicylic acid—SLC22A7—brain—amyotrophic lateral sclerosis	0.000469	0.00479	CbGeAlD
Acetylsalicylic acid—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000463	0.00834	CcSEcCtD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—amyotrophic lateral sclerosis	0.000462	0.194	CrCbGaD
Acetylsalicylic acid—SLC22A6—brain—amyotrophic lateral sclerosis	0.000452	0.00463	CbGeAlD
Acetylsalicylic acid—PTGS2—embryo—amyotrophic lateral sclerosis	0.000419	0.00428	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—PTGS2—amyotrophic lateral sclerosis	0.000359	0.151	CrCbGaD
Acetylsalicylic acid—Salicylic acid—PTGS2—amyotrophic lateral sclerosis	0.000288	0.121	CrCbGaD
Acetylsalicylic acid—ALB—brain—amyotrophic lateral sclerosis	0.000282	0.00288	CbGeAlD
Acetylsalicylic acid—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000267	0.00274	CbGeAlD
Acetylsalicylic acid—ABCB1—embryo—amyotrophic lateral sclerosis	0.000259	0.00265	CbGeAlD
Acetylsalicylic acid—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.00025	0.00255	CbGeAlD
Acetylsalicylic acid—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000239	0.00244	CbGeAlD
Acetylsalicylic acid—PTGS1—nervous system—amyotrophic lateral sclerosis	0.00021	0.00215	CbGeAlD
Acetylsalicylic acid—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000202	0.00207	CbGeAlD
Acetylsalicylic acid—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000201	0.00206	CbGeAlD
Acetylsalicylic acid—CYP2C8—brain—amyotrophic lateral sclerosis	0.000198	0.00203	CbGeAlD
Acetylsalicylic acid—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000193	0.00198	CbGeAlD
Acetylsalicylic acid—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000189	0.00193	CbGeAlD
Acetylsalicylic acid—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000165	0.00169	CbGeAlD
Acetylsalicylic acid—PTGS1—brain—amyotrophic lateral sclerosis	0.000161	0.00164	CbGeAlD
Acetylsalicylic acid—PTGS2—brain—amyotrophic lateral sclerosis	0.000154	0.00157	CbGeAlD
Acetylsalicylic acid—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000148	0.00151	CbGeAlD
Acetylsalicylic acid—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000124	0.00127	CbGeAlD
Acetylsalicylic acid—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00012	0.00122	CbGeAlD
Acetylsalicylic acid—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000117	0.0012	CbGeAlD
Acetylsalicylic acid—ABCB1—brain—amyotrophic lateral sclerosis	9.5e-05	0.000972	CbGeAlD
Acetylsalicylic acid—RPS6KA3—Immune System—ERBB4—amyotrophic lateral sclerosis	2.78e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—APOE—amyotrophic lateral sclerosis	2.78e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CASP9—amyotrophic lateral sclerosis	2.78e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.77e-05	0.000168	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.73e-05	0.000166	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.73e-05	0.000166	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	2.72e-05	0.000165	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.7e-05	0.000164	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	2.67e-05	0.000162	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.66e-05	0.000161	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.63e-05	0.00016	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.62e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD40LG—amyotrophic lateral sclerosis	2.62e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.61e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	2.61e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	2.61e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.6e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.6e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	2.59e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	2.59e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—C3—amyotrophic lateral sclerosis	2.59e-05	0.000157	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	2.57e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.56e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	2.55e-05	0.000155	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	2.54e-05	0.000155	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.53e-05	0.000154	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.53e-05	0.000154	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.52e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.51e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.51e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.47e-05	0.00015	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.45e-05	0.000149	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.44e-05	0.000148	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.43e-05	0.000148	CbGpPWpGaD
Acetylsalicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	2.43e-05	0.000147	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.42e-05	0.000147	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.4e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.39e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.38e-05	0.000144	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	2.37e-05	0.000144	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.37e-05	0.000144	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.36e-05	0.000144	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.35e-05	0.000143	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.35e-05	0.000143	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.35e-05	0.000143	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.33e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.33e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—APOE—amyotrophic lateral sclerosis	2.33e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.32e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	2.32e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	2.32e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—C3—amyotrophic lateral sclerosis	2.31e-05	0.00014	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.3e-05	0.00014	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.3e-05	0.00014	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.28e-05	0.000139	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.27e-05	0.000138	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.27e-05	0.000138	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.26e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.25e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.25e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	2.25e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.22e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.21e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.21e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.21e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.21e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.17e-05	0.000132	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.15e-05	0.00013	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.13e-05	0.000129	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.12e-05	0.000129	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.12e-05	0.000129	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.11e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.1e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.1e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	2.1e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.09e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.09e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.08e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	2.07e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.05e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.05e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	2.04e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.01e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.01e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.01e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	2.01e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.99e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.98e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.98e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—C3—amyotrophic lateral sclerosis	1.97e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.95e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.94e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.94e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.93e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—PTGS2—amyotrophic lateral sclerosis	1.9e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—C3—amyotrophic lateral sclerosis	1.9e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.89e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.89e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	1.87e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.87e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	1.87e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.86e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.86e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.85e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.82e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.81e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.8e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.8e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.8e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.8e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.76e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	1.74e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	1.73e-05	0.000105	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.72e-05	0.000105	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.7e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.7e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ATF1—amyotrophic lateral sclerosis	1.7e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.7e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.69e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.69e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.68e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.68e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.67e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.65e-05	0.0001	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.64e-05	9.98e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	1.62e-05	9.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CASP9—amyotrophic lateral sclerosis	1.62e-05	9.82e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.61e-05	9.76e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.59e-05	9.68e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.57e-05	9.53e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.56e-05	9.46e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.54e-05	9.35e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.53e-05	9.32e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.53e-05	9.29e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.5e-05	9.08e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.5e-05	9.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.48e-05	8.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	1.46e-05	8.88e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.43e-05	8.68e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	1.42e-05	8.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.41e-05	8.58e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.39e-05	8.46e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.39e-05	8.46e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB4—amyotrophic lateral sclerosis	1.38e-05	8.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	1.34e-05	8.15e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.33e-05	8.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.32e-05	8.01e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	1.31e-05	7.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.31e-05	7.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	1.31e-05	7.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD40LG—amyotrophic lateral sclerosis	1.3e-05	7.91e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.29e-05	7.82e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.28e-05	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.27e-05	7.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.24e-05	7.56e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.24e-05	7.51e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.21e-05	7.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.2e-05	7.3e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.19e-05	7.25e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.19e-05	7.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.18e-05	7.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.17e-05	7.11e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.17e-05	7.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.16e-05	7.06e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.15e-05	6.99e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.15e-05	6.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—C3—amyotrophic lateral sclerosis	1.15e-05	6.99e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.15e-05	6.98e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.13e-05	6.86e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.11e-05	6.76e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.1e-05	6.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.08e-05	6.58e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	1.08e-05	6.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.07e-05	6.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	6.51e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.05e-05	6.38e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.05e-05	6.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.05e-05	6.35e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.9e-06	6.02e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.88e-06	6e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.83e-06	5.97e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.79e-06	5.95e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.78e-06	5.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	9.75e-06	5.92e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	9.67e-06	5.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.44e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.36e-06	5.69e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.25e-06	5.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.01e-06	5.47e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.95e-06	5.44e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	8.92e-06	5.42e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.85e-06	5.38e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.85e-06	5.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.82e-06	5.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	8.81e-06	5.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.41e-06	5.11e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	8.41e-06	5.11e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.41e-06	5.11e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.37e-06	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.37e-06	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	8.35e-06	5.07e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.31e-06	5.05e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.28e-06	5.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.04e-06	4.89e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.93e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.51e-06	4.56e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.51e-06	4.56e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.44e-06	4.52e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.15e-06	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.92e-06	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	6.81e-06	4.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.77e-06	4.11e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.73e-06	4.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.57e-06	3.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	6.46e-06	3.92e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.35e-06	3.86e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.04e-06	3.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.83e-06	3.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.82e-06	3.54e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.79e-06	3.52e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.72e-06	3.47e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.68e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.68e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.51e-06	3.35e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	5.41e-06	3.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.35e-06	3.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.32e-06	3.23e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.2e-06	3.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.07e-06	3.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.77e-06	2.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.74e-06	2.88e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.67e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.66e-06	2.83e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.4e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	4.4e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	4.4e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	4.38e-06	2.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.35e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.16e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.93e-06	2.39e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.83e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.74e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.58e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.02e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	3e-06	1.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.82e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.69e-06	1.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.63e-06	1.6e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.45e-06	1.49e-05	CbGpPWpGaD
